HP

Harish Pamnani

Active Director Designated Partner DIN 09608198
DIN 09608198 First appointment May 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Harish Pamnani

Data last updated:

Harish Pamnani is a Designated Partner at Neonest Hospital Llp (since 2022). The company operates in Healthcare.

DIN 09608198
Primary Designation Designated Partner
Industry Healthcare
First Appointment 18 May 2022
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 May 20222018Active

Board colleagues of Harish Pamnani

NameDINCompanyDesignation
Deepika Taneja09608288Neonest Hospital LlpDesignated Partner
Sanjay Saroha08265244Neonest Hospital LlpDesignated Partner
Sushil Saroha08265245Neonest Hospital LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Neonest Hospital Llp
Premium access

Shareholding and investment profile for Harish Pamnani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harish Pamnani

Harish Pamnani currently holds 1 directorship: Neonest Hospital Llp (Designated Partner, since 18 May 2022).

Harish Pamnani was first appointed on 18 May 2022 as Designated Partner at Neonest Hospital Llp.

The current boards of Harish Pamnani's companies include Deepika Taneja (Neonest Hospital Llp), Sanjay Saroha (Neonest Hospital Llp), Sushil Saroha (Neonest Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available